Earlier this month, the long-awaited results of the TAILORx clinical trial were announced.
The findings from this study are important for early stage breast cancer patients with hormone receptor-positive breast cancer. The study results are expected to assist many patients in this group in determining whether chemotherapy should be part of their treatment.
The TAILORx findings are also interesting when viewed as part of a developing trend in treatment for early stage breast cancer away from a one-size-fits all approach toward more personalized care.
The findings were presented at the annual meeting of the American Society for Clinical Oncology (ASCO) and also published in the New England Journal of Medicine (NEJM). Continue reading
Like many of us, I’ve long felt that one of the best ways to help in the fight against cancer is by making a donation to a charity that conducts or funds cancer research.
2016 was not a year for big breakthroughs in cancer research and improving access to quality care. And yet, it was a year in which many of the issues that need to be addressed if we want to ever see those breakthroughs were front and center.
Many of us are interested in making donations in support of cancer research. But figuring out which organizations will make the most effective use of our contributions isn’t always an easy task. This post is the second in a series in which we’re looking at individual charities that focus primarily on cancer research.
A recent study got me thinking again about one of the central issues around clinical trials — why don’t more of us participate?
For a long time, there has been a 
These days the media hype around cancer “breakthroughs” seems to have reached a new high. There have been advances, but there is still such a long way to go before we can say we have real breakthroughs that are changing the outlook for most patients.
The title of this book certainly got my attention and made me curious about what the author had to say. Is the “death” of cancer, or the end of cancer as a deadly disease, really possible? Can we actually win the war on cancer, which has been pronounced a failure by many?
Looking back over the past year, what were some of the big things we learned that contribute to the progress that’s being made against cancer?